UnitedHealth Group Incorporated (UNH) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30..
Borrowing debt
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | (m) | Long-term Debt, Current Maturities |
| Borrowing debt due after one year | 69.50B USD | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | Commercial Paper |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities · Commercial Paper |
| Total assets | 309.73B USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | (m) | $69.50B | (m) | (m) | $309.73B | (m) |
| 2026-03-31 | (m) | (m) | (m) | $71.44B | (m) | (m) | $312.64B | (m) |
| 2025-12-31 | (m) | (m) | (m) | $72.32B | (m) | (m) | $309.58B | (m) |
| 2025-09-30 | (m) | (m) | (m) | $72.40B | (m) | (m) | $315.27B | (m) |
| 2025-06-30 | (m) | (m) | (m) | $73.50B | (m) | (m) | $308.57B | (m) |
| 2025-03-31 | (m) | (m) | (m) | $71.28B | (m) | (m) | $309.79B | (m) |
| 2024-12-31 | (m) | (m) | (m) | $72.36B | (m) | (m) | $298.28B | (m) |
| 2024-09-30 | (m) | (m) | (m) | $74.10B | (m) | (m) | $299.31B | (m) |
| 2024-06-30 | (m) | (m) | (m) | $63.73B | (m) | (m) | $286.06B | (m) |
| 2024-03-31 | (m) | (m) | (m) | $63.85B | $7.30B | (m) | $284.21B | (m) |
| 2023-12-31 | (m) | (m) | (m) | $58.26B | (m) | (m) | $273.72B | (m) |
| 2023-09-30 | (m) | (m) | (m) | $58.08B | $2.60B | (m) | $282.06B | (m) |
| 2023-06-30 | (m) | (m) | (m) | $59.27B | $4.40B | (m) | $280.16B | (m) |
| 2023-03-31 | (m) | (m) | (m) | $60.66B | $8.20B | (m) | $283.68B | (m) |
| 2022-12-31 | (m) | (m) | (m) | $54.51B | (m) | (m) | $245.71B | (m) |
| 2022-09-30 | (m) | (m) | (m) | $45.44B | (m) | (m) | $243.06B | (m) |
| 2022-06-30 | (m) | (m) | (m) | $45.80B | (m) | (m) | $230.17B | (m) |
| 2022-03-31 | (m) | (m) | (m) | $40.80B | (m) | (m) | $221.24B | (m) |
| 2021-12-31 | (m) | (m) | $3.62B | $42.38B | (m) | (m) | $212.21B | (m) |
| 2021-09-30 | (m) | (m) | (m) | $43.34B | (m) | (m) | $213.04B | (m) |
| 2021-06-30 | (m) | (m) | (m) | $44.35B | (m) | (m) | $210.29B | (m) |
| 2021-03-31 | (m) | (m) | (m) | $37.42B | (m) | (m) | $205.17B | (m) |
| 2020-12-31 | (m) | (m) | $4.82B | $38.65B | (m) | (m) | $197.29B | (m) |
| 2020-09-30 | (m) | (m) | (m) | $39.90B | (m) | (m) | $190.97B | (m) |
| 2020-06-30 | (m) | (m) | (m) | $39.90B | (m) | (m) | $192.48B | (m) |
| 2020-03-31 | (m) | (m) | (m) | $35.78B | (m) | (m) | $189.07B | (m) |
| 2019-12-31 | (m) | (m) | $3.87B | $36.81B | (m) | (m) | $173.89B | (m) |
| 2019-09-30 | (m) | (m) | (m) | $38.51B | (m) | (m) | $173.71B | (m) |
| 2019-06-30 | (m) | (m) | (m) | $34.47B | (m) | (m) | $167.20B | (m) |
| 2019-03-31 | (m) | (m) | (m) | $34.42B | (m) | (m) | $161.20B | (m) |
| 2018-12-31 | (m) | (m) | $1.97B | $34.58B | (m) | (m) | $152.22B | (m) |
| 2018-09-30 | (m) | (m) | (m) | $32.05B | (m) | (m) | $151.09B | (m) |
| 2018-06-30 | (m) | (m) | (m) | $32.10B | (m) | (m) | $154.61B | (m) |
| 2018-03-31 | (m) | (m) | (m) | $28.21B | (m) | (m) | $155.57B | (m) |
| 2017-12-31 | (m) | (m) | $2.86B | $28.84B | (m) | (m) | $139.06B | (m) |
| 2017-09-30 | (m) | (m) | (m) | $24.72B | (m) | (m) | $140.43B | (m) |
| 2017-06-30 | (m) | (m) | (m) | $26.20B | (m) | (m) | $138.10B | (m) |
| 2017-03-31 | (m) | (m) | $7.75B | $26.15B | (m) | (m) | $137.16B | (m) |
| 2016-12-31 | (m) | (m) | $7.19B | $25.78B | (m) | (m) | $122.81B | (m) |
| 2016-09-30 | (m) | (m) | $7.20B | $26.02B | (m) | (m) | $123.64B | (m) |
| 2016-06-30 | (m) | (m) | $6.36B | $26.83B | (m) | (m) | $119.60B | (m) |
| 2016-03-31 | (m) | (m) | $6.50B | $27.22B | (m) | (m) | $117.86B | (m) |
| 2015-12-31 | (m) | (m) | $6.63B | $25.46B | (m) | (m) | $111.38B | (m) |
| 2015-09-30 | (m) | (m) | $5.77B | $26.02B | (m) | (m) | $108.27B | (m) |
| 2015-06-30 | (m) | (m) | $2.69B | $15.38B | (m) | (m) | $91.42B | (m) |
| 2015-03-31 | (m) | (m) | $2.80B | $15.58B | (m) | (m) | $89.72B | (m) |
| 2014-12-31 | (m) | (m) | $1.40B | $16.01B | (m) | (m) | $86.38B | (m) |
| 2014-09-30 | (m) | (m) | $2.92B | $14.59B | (m) | (m) | $85.43B | (m) |
| 2014-06-30 | (m) | (m) | $2.12B | $14.63B | (m) | (m) | $85.47B | (m) |
| 2014-03-31 | (m) | (m) | $2.24B | $14.52B | (m) | (m) | $84.62B | (m) |
| 2013-12-31 | (m) | (m) | $1.97B | $14.89B | (m) | (m) | $81.88B | (m) |
| 2013-09-30 | (m) | (m) | $1.90B | $14.89B | (m) | (m) | $81.86B | (m) |
| 2013-06-30 | (m) | (m) | $1.09B | $15.54B | (m) | (m) | $80.20B | (m) |
| 2013-03-31 | (m) | (m) | $2.39B | $15.66B | (m) | (m) | $83.13B | (m) |
| 2012-12-31 | (m) | (m) | $2.71B | $14.04B | (m) | (m) | $80.89B | (m) |
| 2012-09-30 | (m) | (m) | $1.85B | $11.15B | (m) | (m) | $71.70B | (m) |
| 2012-06-30 | (m) | (m) | $1.46B | $11.16B | (m) | (m) | $73.47B | (m) |
| 2012-03-31 | (m) | (m) | $1.77B | $11.08B | (m) | (m) | $72.69B | (m) |
| 2011-12-31 | (m) | (m) | $982.00M | $10.66B | (m) | (m) | $67.89B | (m) |
| 2011-09-30 | (m) | (m) | $2.36B | $9.55B | (m) | (m) | $70.91B | (m) |
| 2011-06-30 | (m) | (m) | $1.69B | $9.44B | (m) | (m) | $66.11B | (m) |
| 2011-03-31 | (m) | (m) | $2.29B | $9.36B | (m) | (m) | $65.33B | (m) |
| 2010-12-31 | (m) | (m) | $2.48B | $8.66B | (m) | (m) | $63.06B | (m) |
| 2010-09-30 | (m) | (m) | $2.93B | $8.08B | (m) | (m) | $63.02B | (m) |
| 2010-06-30 | (m) | (m) | $2.68B | $8.04B | (m) | (m) | $60.42B | (m) |
| 2010-03-31 | (m) | (m) | $2.52B | $8.00B | (m) | (m) | $59.54B | (m) |
| 2009-12-31 | (m) | (m) | $2.16B | $9.01B | (m) | (m) | $59.05B | (m) |
| 2009-09-30 | (m) | (m) | $500.00M | $10.69B | (m) | (m) | $57.45B | (m) |
| 2009-06-30 | (m) | (m) | (m) | $10.71B | (m) | (m) | $55.89B | (m) |
| 2008-12-31 | (m) | (m) | (m) | $11.34B | (m) | (m) | $55.81B | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health, Inc. (ELV) | United States | $86.364B | 16.90 |
| Cigna Group (CI) | United States | $70.160B | 10.44 |
| HUMANA INC (HUM) | United States | $45.651B | 18.44 |
| CENTENE CORP (CNC) | United States | $30.588B | -6.22 |
| MOLINA HEALTHCARE, INC. (MOH) | United States | $10.091B | -1,697.50 |
| Alignment Healthcare, Inc. (ALHC) | United States | $1.593B | 121.28 |
| TRUPANION, INC. (TRUP) | United States | $0.984B |